Literature DB >> 28958862

Antifungal Therapy in Equine Ocular Mycotic Infections.

Eric C Ledbetter1.   

Abstract

Fungi are clinically important causes of ocular infections in the horse. Keratomycosis is the most common; however, a diverse range of mycotic infections, affecting numerous ocular tissues, may be encountered. Many equine mycoses are diagnostic and therapeutic challenges. Prompt and appropriate treatment is essential to minimize morbidity and reduce the likelihood of vision loss. Knowledge of the characteristics and properties of equine ophthalmology antifungal medications is essential to selecting an optimal treatment strategy, including selection of appropriate medication and effective administration route. Newer delivery methods and devices are available and can contribute to an improved outcome in select situations.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antifungal; Equine; Fungal keratitis; Horse; Keratomycosis; Mycotic infection

Mesh:

Substances:

Year:  2017        PMID: 28958862     DOI: 10.1016/j.cveq.2017.08.001

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  3 in total

1.  Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States.

Authors:  Megan Cullen; Megan E Jacob; Vicki Cornish; Ian Q VanderSchel; Henry Van T Cotter; Marc A Cubeta; Ignazio Carbone; Brian C Gilger
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

2.  Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles.

Authors:  Minna P Mustikka; Thomas S C Grönthal; Elina M Pietilä
Journal:  Vet Ophthalmol       Date:  2019-07-31       Impact factor: 1.644

3.  Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies.

Authors:  Mariano Mora-Pereira; Eva M Abarca; Sue Duran; William Ravis; Richard J McMullen; Britta M Fischer; Yann-Huei Phillip Lee; Anne A Wooldridge
Journal:  BMC Vet Res       Date:  2020-04-16       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.